{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:12:35Z","timestamp":1791065555449,"version":"4.1.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,18]],"date-time":"2017-12-18T00:00:00Z","timestamp":1513555200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s00432-017-2560-x","type":"journal-article","created":{"date-parts":[[2017,12,18]],"date-time":"2017-12-18T00:36:16Z","timestamp":1513557376000},"page":"99-107","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cardiovascular effects of Hodgkin\u2019s lymphoma: a review of literature"],"prefix":"10.1007","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7783-3786","authenticated-orcid":false,"given":"Aasems","family":"Jacob","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bragadheeswar","family":"Thyagarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monisha Priyadarshini","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasreen","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sharon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,18]]},"reference":[{"key":"2560_CR1","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1200\/JCO.2004.09.109","volume":"22","author":"MJ Adams","year":"2004","unstructured":"Adams MJ, Lipsitz SR, Colan SD et al (2004) Cardiovascular status in long-term survivors of Hodgkin\u2019s disease treated with chest radiotherapy. J Clin Oncol 22:3139","journal-title":"J Clin Oncol"},{"issue":"42","key":"2560_CR2","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","volume":"36","author":"Y Adler","year":"2015","unstructured":"Adler Y, Charron P, Imazio M et al (2015) European Society of Cardiology (ESC) 2015 ESC guidelines for the diagnosis and management of pericardial diseases: the task force for the diagnosis and management of pericardial diseases of the European Society of Cardiology (ESC) endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 36(42):2921\u20132964","journal-title":"Eur Heart J"},{"key":"2560_CR3","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.amjcard.2004.06.041","volume":"94","author":"MW Akhter","year":"2004","unstructured":"Akhter MW, Aronson D, Bitar F, Khan S, Singh H et al (2004) Effect of elevated admission serum creatinine and its worsening on outcome in hospitalised patients with decompensated heart failure. Am J Cardiol 94:957\u2013960","journal-title":"Am J Cardiol"},{"key":"2560_CR4","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1200\/JCO.2003.07.131","volume":"21","author":"BM Aleman","year":"2003","unstructured":"Aleman BM, van den Belt-Dusebout AW, Klokman WJ et al (2003) Long-term cause-specific mortality of patients treated for Hodgkin\u2019s disease. J Clin Oncol 21:3431\u20133439","journal-title":"J Clin Oncol"},{"issue":"5","key":"2560_CR5","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1182\/blood-2006-07-034405","volume":"109","author":"BM Aleman","year":"2007","unstructured":"Aleman BM, van den Belt-Dusebout AW, De Bruin ML et al (2007) Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 109(5):1878\u20131886","journal-title":"Blood"},{"issue":"12","key":"2560_CR6","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.clml.2015.07.638","volume":"15","author":"SG Al-Kindi","year":"2015","unstructured":"Al-Kindi SG, Abu-Zeinah GF, Kim CH, Hejjaji V, William BM, Caimi PF, Oliveira GH (2015) Trends and disparities in cardiovascular mortality among survivors of Hodgkin lymphoma. Clin Lymphoma Myeloma Leuk 15(12):748\u2013752","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2560_CR7","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1200\/JCO.2015.64.0409","volume":"34","author":"SH Armenian","year":"2016","unstructured":"Armenian SH, Xu L, Ky B et al (2016) Cardiovascular disease among survivors of adult-onset cancer: a community-based retrospective cohort study. J Clin Oncol 34:1122\u20131130","journal-title":"J Clin Oncol"},{"issue":"8","key":"2560_CR8","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","volume":"35","author":"SH Armenian","year":"2017","unstructured":"Armenian SH, Lacchetti C, Barac A et al (2017) Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 35(8):893\u2013911. https:\/\/doi.org\/10.1200\/JCO.2016.70.5400","journal-title":"J Clin Oncol"},{"issue":"5","key":"2560_CR9","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/pbc.20993","volume":"49","author":"H Bashir","year":"2007","unstructured":"Bashir H, Hudson MM, Kaste SC, Howard SC, Krasin M, Metzger ML (2007) Pericardial involvement at diagnosis in pediatric Hodgkin lymphoma patients. Pediatr Blood Cancer 49(5):666\u2013671","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"2560_CR10","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.4081\/hr.2010.e8","volume":"2","author":"F Bilora","year":"2010","unstructured":"Bilora F, Veronese F, Zancan A, Biasiolo M, Pomerri F, Muzzio PC (2010) Autonomic dysfunction in Hodgkin and non-Hodgkin lymphoma. A paraneoplastic syndrome? Hematol Rep 2(1):e8. https:\/\/doi.org\/10.4081\/hr.2010.e8","journal-title":"Hematol Rep"},{"issue":"2","key":"2560_CR11","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2147\/TCRM.S1351","volume":"4","author":"G Birgeg\u00e5rd","year":"2008","unstructured":"Birgeg\u00e5rd G (2008) Managing anemia in lymphoma and multiple myeloma. Ther Clin Risk Manag 4(2):527\u2013539","journal-title":"Ther Clin Risk Manag"},{"key":"2560_CR12","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/j.jacc.2013.02.072","volume":"61","author":"X Bosch","year":"2013","unstructured":"Bosch X, Rovira M, Sitges M et al (2013) Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (prevention of left ventricular dysfunction with enalapril and carvedilol in patients submitted to intensive chemotherapy for the treatment of malignant hemopathies). J Am Coll Cardiol 61:2355\u20132362","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2560_CR13","first-page":"681","volume":"10","author":"MD Brand","year":"2001","unstructured":"Brand MD, Abadi CA, Aurigemma GP, Dauerman HL, Meyer TE (2001) Radiation-associated valvular heart disease in Hodgkin\u2019s disease is associated with characteristic thickening and fibrosis of the aortic-mitral curtain. J Heart Valve Dis 10(5):681\u2013685","journal-title":"J Heart Valve Dis"},{"issue":"2","key":"2560_CR14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.5543\/tkda.2012.01793","volume":"40","author":"M Cagdas","year":"2012","unstructured":"Cagdas M, Velibey Y, Calik AN, Satilmis S (2012) An incidentally detected paraaortic mass diagnosed as bulky disease. Turk Kardiyol Dern Ars 40(2):197","journal-title":"Turk Kardiyol Dern Ars"},{"issue":"4","key":"2560_CR15","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1185\/030079906X100096","volume":"22","author":"I Cavill","year":"2006","unstructured":"Cavill I, Auerbach M, Bailie GR, Barrett-Lee P, Beguin Y, Kaltwasser P, Littlewood T, Macdougall IC, Wilson K (2006) Iron and the anaemia of chronic disease: a review and strategic recommendations. Curr Med Res Opin 22(4):731\u2013737","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"2560_CR16","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.radonc.2011.08.040","volume":"101","author":"L Cella","year":"2011","unstructured":"Cella L, Liuzzi R, Conson M et al (2011) Dosimetric predictors of asymptomatic heart valvular dysfunction following mediastinal irradiation for Hodgkin\u2019s lymphoma. Radiother Oncol 101(2):316\u2013321","journal-title":"Radiother Oncol"},{"key":"2560_CR17","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1200\/JCO.2009.22.8460","volume":"27","author":"AB Chen","year":"2009","unstructured":"Chen AB, Punglia RS, Kuntz KM et al (2009) Cost effectiveness and screening interval of lipid screening in Hodgkin\u2019s lymphoma survivors. J Clin Oncol 27:5383","journal-title":"J Clin Oncol"},{"key":"2560_CR18","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1148\/radiographics.21.2.g01mr15439","volume":"21","author":"C Chiles","year":"2001","unstructured":"Chiles C, Woodard PK, Gutierrez FR, Link KM (2001) Metastatic involvement of the heart and pericardium: CT and MR imaging. Radiographics 21:439\u2013449","journal-title":"Radiographics"},{"issue":"1","key":"2560_CR19","first-page":"116","volume":"129","author":"JE Crowe","year":"1975","unstructured":"Crowe JE (1975) Cardiophrenic adenopathy in Hodgkin disease. Am J Dis Child 129(1):116\u2013117","journal-title":"Am J Dis Child"},{"key":"2560_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv008","author":"DJ Cutter","year":"2015","unstructured":"Cutter DJ, Schaapveld M, Darby SC et al (2015) Risk for valvular heart disease after treatment for Hodgkin lymphoma. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djv008","journal-title":"J Natl Cancer Inst"},{"key":"2560_CR21","first-page":"270","volume":"41","author":"WB Dawson","year":"1990","unstructured":"Dawson WB, Mayo JR, Muller NL (1990) Computed tomography of cardiac and pericardial tumors. Can Assoc Radiol J 41:270\u2013275","journal-title":"Can Assoc Radiol J"},{"key":"2560_CR22","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/jnci\/djp147","volume":"101","author":"ML Bruin De","year":"2009","unstructured":"De Bruin ML, Dorresteijn LD, van\u2019t Veer MB et al (2009) Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma. J Natl Cancer Inst 101:928","journal-title":"J Natl Cancer Inst"},{"key":"2560_CR23","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1200\/JCO.1991.9.3.438","volume":"9","author":"LF Diehl","year":"1991","unstructured":"Diehl LF, Hopper KD, Giguere J, Granger E, Lesar M (1991) The pattern of intrathoracic Hodgkin\u2019s disease assessed by computed tomography. J Clin Oncol 9:438\u2013443","journal-title":"J Clin Oncol"},{"key":"2560_CR24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1470-2045(03)01320-2","volume":"5","author":"V Diehl","year":"2004","unstructured":"Diehl V, Thomas RK, Re D (2004) Part II: Hodgkin\u2019s lymphoma\u2014diagnosis and treatment. Lancet Oncol 5:19\u201326","journal-title":"Lancet Oncol"},{"issue":"1","key":"2560_CR25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/hrt.2009.190405","volume":"97","author":"SW Dubrey","year":"2011","unstructured":"Dubrey SW, Hawkins PN, Falk RH (2011) Amyloid diseases of the heart: assessment, diagnosis, and referral. Heart [British Cardiac Society] 97(1):75\u201384","journal-title":"Heart [British Cardiac Society]"},{"issue":"13","key":"2560_CR26","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1200\/JCO.2009.25.1835","volume":"28","author":"A Engert","year":"2010","unstructured":"Engert A, Josting A, Haverkamp H et al (2010) Epoetin alfa in patients with advanced-stage Hodgkin\u2019s lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial. J Clin Oncol 28(13):2239\u20132245","journal-title":"J Clin Oncol"},{"key":"2560_CR27","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2337\/diacare.8.5.491","volume":"8","author":"DJ Ewing","year":"1985","unstructured":"Ewing DJ, Martyn CN, Young RJ et al (1985) The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 8:491\u2013498","journal-title":"Diabetes Care"},{"key":"2560_CR28","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/ajh.21840","volume":"85","author":"P Georgakopoulos","year":"2010","unstructured":"Georgakopoulos P, Roussou P, Matsakas E et al (2010) Cardioprotective effect of metoprolol and enalapril in doxorubicin-treated lymphoma patients: a prospective, parallel-group, randomized, controlled study with 36-month follow-up. Am J Hematol 2010 85:894","journal-title":"Am J Hematol"},{"key":"2560_CR29","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jacc.2014.11.035","volume":"65","author":"JD Groarke","year":"2015","unstructured":"Groarke JD, Tanguturi VK, Hainer J et al (2015) Abnormal exercise response in long-term survivors of hodgkin lymphoma treated with thoracic irradiation: evidence of cardiac autonomic dysfunction and impact on outcomes. J Am Coll Cardiol 65:573","journal-title":"J Am Coll Cardiol"},{"key":"2560_CR30","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/eurheartj\/ehw022","volume":"37","author":"G Gulati","year":"2016","unstructured":"Gulati G, Heck SL, Ree AH et al (2016) Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 \u00d7 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol. Eur Heart J 37:1671","journal-title":"Eur Heart J"},{"issue":"5","key":"2560_CR31","first-page":"401","volume":"49","author":"A Hadar","year":"2004","unstructured":"Hadar A, Sheiner E, Press F, Katz A, Katz M (2004) Dilated cardiomyopathy in a pregnant woman after doxorubicin and radiotherapy for Hodgkin\u2019s disease: a case report. J Reprod Med 49(5):401\u2013403","journal-title":"J Reprod Med"},{"key":"2560_CR32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4103\/2156-7514.172971","volume":"5","author":"A Hajra","year":"2015","unstructured":"Hajra A, Bandyopadhyay D, Layek M, Mukhopadhyay S (2015) Cardiac tamponade as initial presentation of Hodgkin lymphoma. J Clin Imaging Sci 5:67","journal-title":"J Clin Imaging Sci"},{"key":"2560_CR33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1053-4296(96)80018-X","volume":"6","author":"SL Hancock","year":"1996","unstructured":"Hancock SL, Hoppe RT (1996) Long-term complications of treatment and causes of mortality after Hodgkin\u2019s disease. Semin Radiat Oncol 6:225\u2013242","journal-title":"Semin Radiat Oncol"},{"issue":"2","key":"2560_CR34","first-page":"196","volume":"96","author":"S Hasan","year":"2004","unstructured":"Hasan S, Dinh K, Lombardo F et al (2004) Doxorubicin cardiotoxicity in African Americans. J Natl Med Assoc 96(2):196\u2013199","journal-title":"J Natl Med Assoc"},{"key":"2560_CR35","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.ahj.2004.12.026","volume":"150","author":"PA Heidenreich","year":"2005","unstructured":"Heidenreich PA, Hancock SL, Vagelos RH et al (2005) Diastolic dysfunction after mediastinal irradiation. Am Heart J 150:977","journal-title":"Am Heart J"},{"key":"2560_CR36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1200\/JCO.2006.07.0805","volume":"25","author":"PA Heidenreich","year":"2007","unstructured":"Heidenreich PA, Schnittger I, Strauss HW et al (2007) Screening for coronary artery disease after mediastinal irradiation for Hodgkin\u2019s disease. J Clin Oncol 25:43","journal-title":"J Clin Oncol"},{"issue":"2","key":"2560_CR37","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0002-9149(03)00546-0","volume":"92","author":"D Hering","year":"2003","unstructured":"Hering D, Faber L, Horstkotte D (2003) Echocardiographic features of radiation-associated valvular disease. Am J Cardiol 92(2):226\u2013230","journal-title":"Am J Cardiol"},{"issue":"5","key":"2560_CR38","first-page":"527","volume":"70","author":"M Janeczek","year":"2012","unstructured":"Janeczek M, B\u0105ka\u0142a W (2012) Acquired pulmonary stenosis due to Hodgkin\u2019s lymphoma. Kardiol Pol 70(5):527\u2013528 (Polish)","journal-title":"Kardiol Pol"},{"key":"2560_CR39","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/j.jacc.2006.07.052","volume":"48","author":"N Kalay","year":"2006","unstructured":"Kalay N, Basar E, Ozdogru I et al (2006) Protective effects of carvedilol against anthracycline-induced cardiomyopathy. J Am Coll Cardiol 48:2258","journal-title":"J Am Coll Cardiol"},{"key":"2560_CR40","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.ijcard.2012.06.023","volume":"167","author":"MG Kaya","year":"2013","unstructured":"Kaya MG, Ozkan M, Gunebakmaz O et al (2013) Protective effects of nebivolol against anthracycline-induced cardiomyopathy: a randomized control study. Int J Cardiol 167:2306","journal-title":"Int J Cardiol"},{"issue":"1","key":"2560_CR41","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/archinte.1974.00320190147025","volume":"134","author":"MH Keelan Jr","year":"1974","unstructured":"Keelan MH Jr, Rudders RA (1974) Successful treatment of radiation pericarditis with corticosteroids. Arch Intern Med 134(1):145\u2013147","journal-title":"Arch Intern Med"},{"issue":"6","key":"2560_CR42","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2143\/AC.60.6.2004940","volume":"60","author":"J Korecki","year":"2005","unstructured":"Korecki J, Kami\u0144ski KA, Lisowska A, Musia\u0142 WJ (2005) Supraventricular tachycardia and pulmonary hypertension at the presentation of Hodgkin\u2019s disease. Acta Cardiol 60(6):655\u2013657","journal-title":"Acta Cardiol"},{"key":"2560_CR43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0002-9149(92)91393-I","volume":"70","author":"RL Larsen","year":"1992","unstructured":"Larsen RL, Jakacki RI, Vetter VL et al (1992) Electrocardiographic changes and arrhythmias after cancer therapy in children and young adults. Am J Cardiol 70:73","journal-title":"Am J Cardiol"},{"issue":"7","key":"2560_CR44","doi-asserted-by":"crossref","first-page":"254","DOI":"10.5694\/j.1326-5377.1976.tb130146.x","volume":"2","author":"O Larsson","year":"1976","unstructured":"Larsson O, Stein G, Seivers J (1976) Hodgkin\u2019s disease presenting as pericarditis. Med J Aust 2(7):254\u2013255","journal-title":"Med J Aust"},{"key":"2560_CR45","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa035153","volume":"351","author":"SE Lipshultz","year":"2004","unstructured":"Lipshultz SE, Rifai N, Dalton VM et al (2004) The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia. N Engl J Med 351:145\u2013153","journal-title":"N Engl J Med"},{"key":"2560_CR46","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.ijcard.2012.10.079","volume":"167","author":"M Lotrionte","year":"2013","unstructured":"Lotrionte M, Palazzoni G, Abbate A et al (2013) Cardiotoxicity of a non-pegylated liposomal doxorubicin-based regimen versus an epirubicin-based regimen for breast cancer: the LITE (liposomal doxorubicin\u2013investigational chemotherapy\u2013tissue doppler imaging evaluation) randomized pilot study. Int J Cardiol 167:1055\u20131057","journal-title":"Int J Cardiol"},{"issue":"4","key":"2560_CR47","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.ijrobp.2009.12.054","volume":"79","author":"W Machann","year":"2010","unstructured":"Machann W, Beer M, Breunig M et al (2010) Cardiac magnetic resonance imaging findings in 20-year survivors of mediastinal radiotherapy for Hodgkin\u2019s disease. Int J Radiat Oncol Biol Phys 79(4):1117\u20131123","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2560_CR48","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0022-5223(96)70046-6","volume":"112","author":"EA Maher","year":"1996","unstructured":"Maher EA, Shepherd FA, Todd TJ (1996) Pericardial sclerosis as the primary management of malignant pericardial effusion and cardiac tamponade. J Thorac Cardiovasc Surg 112:637\u2013643","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"2560_CR49","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.ijrobp.2012.08.041","volume":"85","author":"MV Maraldo","year":"2013","unstructured":"Maraldo MV, Aznar MC, Vogelius IR, Petersen PM, Specht L (2013) Involved node radiation therapy: an effective alternative in early-stage Hodgkin lymphoma. Int J Radiat Oncol Biol Phys 85(4):1057\u20131065","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"2560_CR50","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3109\/02841867309131095","volume":"12","author":"RD Marks Jr","year":"1973","unstructured":"Marks RD Jr, Agarwal SK, Constable WC (1973) Radiation induced pericarditis in Hodgkin\u2019s disease. Acta Radiol Ther Phys Biol 12(4):305 \u2013 12","journal-title":"Acta Radiol Ther Phys Biol"},{"key":"2560_CR51","first-page":"85","volume":"9","author":"Q Meng","year":"2002","unstructured":"Meng Q, Lai H, Lima J et al (2002) Echocardiographic and pathological characteristics of cardiac metastasis in patients with lymphoma. Oncol Rep 9:85\u201388","journal-title":"Oncol Rep"},{"key":"2560_CR52","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/0002-8703(92)90988-8","volume":"124","author":"A Millaire","year":"1992","unstructured":"Millaire A, Wurtz A de GP et al (1992) Malignant pericardial effusions: usefulness of pericardioscopy. Am Heart J 124:1030\u20131034","journal-title":"Am Heart J"},{"key":"2560_CR53","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1200\/JCO.2002.08.021","volume":"20","author":"AK Ng","year":"2002","unstructured":"Ng AK, Bernardo MP, Weller E et al (2002) Long-term survival and competing causes of death in patients with early-stage Hodgkin\u2019s disease treated at age 50 or younger. J Clin Oncol 20:2101\u20132108","journal-title":"J Clin Oncol"},{"key":"2560_CR54","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00000441-197609000-00005","volume":"272","author":"CD Petersen","year":"1976","unstructured":"Petersen CD, Robinson WA, Kurnick JE (1976) Involvement of the heart and pericardium in the malignant lymphomas. Am J Med Sci 272:161\u2013165","journal-title":"Am J Med Sci"},{"issue":"25","key":"2560_CR55","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1200\/JCO.2006.10.4976","volume":"25","author":"MC Pinder","year":"2007","unstructured":"Pinder MC, Duan Z, Goodwin JS et al (2007) Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer. J Clin Oncol 25(25):3808\u20133815","journal-title":"J Clin Oncol"},{"issue":"33","key":"2560_CR56","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1200\/JCO.2010.29.2201","volume":"28","author":"JD Rizzo","year":"2010","unstructured":"Rizzo JD, Brouwers M, Hurley P et al (2010) American Society of Clinical Oncology; American Society of Hematology. American Society of Clinical Oncology\/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. J Clin Oncol 28(33):4996\u20135010","journal-title":"J Clin Oncol"},{"key":"2560_CR57","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0002-9149(68)90250-6","volume":"22","author":"WC Roberts","year":"1968","unstructured":"Roberts WC, Glancy DL, DeVita VT Jr (1968) Heart in malignant lymphoma [Hodgkin\u2019s disease, lymphosarcoma, reticulum cell sarcoma and mycosis fungoides]. A study of 196 autopsy cases. Am J Cardiol 22:85\u2013107","journal-title":"Am J Cardiol"},{"key":"2560_CR58","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0360-3016(01)01798-9","volume":"51","author":"U Ruhl","year":"2001","unstructured":"Ruhl U, Albrecht M, Dieckmann K et al (2001) Response-adapted radiotherapy in the treatment of pediatric Hodgkin\u2019s disease: an interim report at 5 years of the German GPOH-HD 95 trial. Int J Radiat Oncol Biol Phys 51:1209\u20131218","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2560_CR59","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1200\/JCO.1987.5.1.27","volume":"5","author":"A Santoro","year":"1987","unstructured":"Santoro A, Bonadonna G, Valagussa P et al (1987) Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin\u2019s disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy. J Clin Oncol 5:27","journal-title":"J Clin Oncol"},{"issue":"12","key":"2560_CR60","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1212\/WNL.32.12.1380","volume":"32","author":"S Schachter","year":"1982","unstructured":"Schachter S, Freeman R (1982) Transient ischemic attack and adriamycin cardiomyopathy. Neurology 32(12):1380\u20131381","journal-title":"Neurology"},{"key":"2560_CR61","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0733-8651(18)30717-3","volume":"2","author":"FJ Schoen","year":"1984","unstructured":"Schoen FJ, Berger BM, Guerina NG (1984) Cardiac effects of noncardiac neoplasms. Cardiol Clin 2:657\u2013670","journal-title":"Cardiol Clin"},{"key":"2560_CR62","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/annonc\/mdr348","volume":"23","author":"C Serrano","year":"2012","unstructured":"Serrano C, Cort\u00e9s J, De Mattos-Arruda L et al (2012) Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors. Ann Oncol 23:897\u2013902","journal-title":"Ann Oncol"},{"key":"2560_CR63","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00001622-199703000-00011","volume":"9","author":"FA Shepherd","year":"1997","unstructured":"Shepherd FA (1997) Malignant pericardial effusion. Curr Opin Oncol 9:170\u2013174","journal-title":"Curr Opin Oncol"},{"issue":"1","key":"2560_CR64","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66(1):7\u201330. https:\/\/doi.org\/10.3322\/caac.21332","journal-title":"CA Cancer J Clin"},{"key":"2560_CR65","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ijrobp.2013.05.005","volume":"89","author":"L Specht","year":"2014","unstructured":"Specht L, Yahalom J, Illidge T et al (2014) Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the International Lymphoma Radiation Oncology Group (ILROG). Int J Radiat Oncol Biol Phys 89:854\u2013862","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2560_CR66","doi-asserted-by":"crossref","first-page":"827","DOI":"10.7326\/0003-4819-126-10-199705150-00018","volume":"126","author":"LJ Steinherz","year":"1997","unstructured":"Steinherz LJ (1997) Anthracycline-induced cardiotoxicity. Ann Intern Med 126:827\u2013828","journal-title":"Ann Intern Med"},{"issue":"3","key":"2560_CR67","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/jnci\/djk029","volume":"99","author":"AJ Swerdlow","year":"2007","unstructured":"Swerdlow AJ, Higgins CD, Smith P et al (2007) Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. J Natl Cancer Inst 99(3):206\u2013214","journal-title":"J Natl Cancer Inst"},{"key":"2560_CR68","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1161\/01.CIR.0000087606.18453.FD","volume":"108","author":"DR Talreja","year":"2003","unstructured":"Talreja DR, Edwards WD, Danielson GK et al (2003) Constrictive pericarditis in 26 patients with histologically normal pericardial thickness. Circulation 108:1852","journal-title":"Circulation"},{"issue":"1","key":"2560_CR69","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1200\/JCO.1998.16.1.27","volume":"16","author":"U Tirelli","year":"1998","unstructured":"Tirelli U, Errante D, Van Glabbeke M et al (1998) CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin\u2019s lymphoma. results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group. J Clin Oncol 16(1):27\u201334","journal-title":"J Clin Oncol"},{"issue":"4","key":"2560_CR70","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2141.1993.tb03137.x","volume":"84","author":"ML Turner","year":"1993","unstructured":"Turner ML, Boland OM, Parker AC, Ewing DJ (1993) Subclinical autonomic dysfunction in patients with Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphoma. Br J Haematol 84(4):623\u2013626","journal-title":"Br J Haematol"},{"issue":"6","key":"2560_CR71","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jamainternmed.2015.1180","volume":"175","author":"FA Nimwegen van","year":"2015","unstructured":"van Nimwegen FA, Schaapveld M, Janus CP, Krol AD, Petersen EJ, Raemaekers JM, Kok WE, Aleman BM, van Leeuwen FE (2015) Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk. JAMA Intern Med 175(6):1007\u20131017","journal-title":"JAMA Intern Med"},{"key":"2560_CR72","first-page":"CD005008","volume":"3","author":"EC Dalen van","year":"2016","unstructured":"van Dalen EC, van der Pal HJ, Kremer LC (2016) Different dosage schedules for reducing cardiotoxicity in people with cancer receiving anthracycline chemotherapy. Cochrane Database Syst Rev 3:CD005008","journal-title":"Cochrane Database Syst Rev"},{"key":"2560_CR73","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1200\/JCO.2015.63.4444","volume":"34","author":"FA Nimwegen van","year":"2016","unstructured":"van Nimwegen FA, Schaapveld M, Cutter DJ et al (2016) Radiation dose-response relationship for risk of coronary heart disease in survivors of Hodgkin lymphoma. J Clin Oncol 34:235\u2013243","journal-title":"J Clin Oncol"},{"key":"2560_CR74","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0002-8703(72)90445-0","volume":"83","author":"MA Varat","year":"1972","unstructured":"Varat MA, Adolph RJ, Fowler NO (1972) Cardiovascular effects of anemia. Am Heart J 83:415\u2013426","journal-title":"Am Heart J"},{"key":"2560_CR75","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0046-8177(96)90447-5","volume":"27","author":"JP Veinot","year":"1996","unstructured":"Veinot JP, Edwards WD (1996) Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases. Hum Pathol 27:766\u2013773","journal-title":"Hum Pathol"},{"issue":"20","key":"2560_CR76","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1136\/heartjnl-2015-307907","volume":"101","author":"SA Virk","year":"2015","unstructured":"Virk SA, Chandrakumar D, Villanueva C, Wolfenden H, Liou K, Cao C (2015) Systematic review of percutaneous interventions for malignant pericardial effusion. Heart 101(20):1619\u20131626. https:\/\/doi.org\/10.1136\/heartjnl-2015-307907 (Review)","journal-title":"Heart"},{"key":"2560_CR77","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1600-0609.1988.tb00853.x","volume":"40","author":"N Xiros","year":"1988","unstructured":"Xiros N, Binder T, Anger B, B\u00f6hlke J, Heimpel H (1988) Idiopathic thrombocytopenic purpura and Autoimmune hemolytic anemia in Hodgkin\u2019s disease. Eur J Haematol 40:437\u2013441","journal-title":"Eur J Haematol"},{"issue":"2","key":"2560_CR78","first-page":"28","volume":"60","author":"GN Zubrikhina","year":"2015","unstructured":"Zubrikhina GN, Blindar VN, Matveeva II, Demina EA (2015) The characteristics of anemic syndrome in patients with prevalent phases of Hodgkin lymphoma before treatment. Klin Lab Diagn 60(2):28\u201332 (Russian)","journal-title":"Klin Lab Diagn"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-017-2560-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-017-2560-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-017-2560-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T01:06:35Z","timestamp":1570496795000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-017-2560-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,18]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["2560"],"URL":"https:\/\/doi.org\/10.1007\/s00432-017-2560-x","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,18]]}}}